Announcements Trials
Browse Landscape

Phase

Phase 2 5

Status

Completed 3Recruiting 2

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 5Other 2Sarcoma 1

Conditions

Squamous Cell Carcinoma of Head and Neck 281Head and Neck Neoplasms 258Nasopharyngeal Carcinoma 127Oropharyngeal Neoplasms 57Carcinoma, Squamous Cell 54Nasopharyngeal Neoplasms 41Laryngeal Neoplasms 35Mouth Neoplasms 30Hypopharyngeal Neoplasms 29Carcinoma 24Salivary Gland Neoplasms 19Carcinoma, Non-Small-Cell Lung 16Tongue Neoplasms 15Neoplasm Metastasis 13Laryngeal Diseases 13Recurrence 12Neoplasms 10Parkinson Disease 4, Autosomal Dominant Lewy Body 8Mucositis 8Stomach Neoplasms 7Pharyngeal Neoplasms 7Papillomavirus Infections 7Ovarian Neoplasms 7Lung Neoplasms 7Radiation Injuries 6Pancreatic Neoplasms 6Neoplasms, Squamous Cell 6Esophageal Neoplasms 6Colorectal Neoplasms 6Thyroid Neoplasms 5

Interventions

Low-Level Light Therapy 6Cisplatin 5avasopasem manganese 4Radiotherapy, Intensity-Modulated 4Standard of Care 3Injections 3Fibroblast Growth Factor 7 3golotimod 2Water 2Vitamin B 12 2Sodium Bicarbonate 2Saline Solution 2Radiotherapy 2RRx-001 2Propolis 2Mouthwashes 2Honey 2Gentamicins 2whole grape extract 1sargramostim 1samital 1regramostim 1oxycodone-acetaminophen 1dusquetide 1clazakizumab 1brilacidin 1alfacalcidol 1Xylitol 1Valacyclovir 1Traumeel S 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Stomatitis × Cisplatin × Head & Neck × Clear all
NCT06532279 2026-05-04

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NRG Oncology

Phase 2 Recruiting
98 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT05966194 2024-11-15

KEVLARx

EpicentRx, Inc.

Phase 2 Recruiting
216 enrolled
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT03515538 2024-11-04

PREVLAR

EpicentRx, Inc.

Phase 2 Completed
53 enrolled 15 charts
Head & NeckOther

Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT04529850 2022-08-16

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

Galera Therapeutics, Inc.

Phase 2 Completed
38 enrolled 10 charts
Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT02508389 2021-09-20

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Galera Therapeutics, Inc.

Phase 2 Completed
223 enrolled 17 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡